Publication & Citation Trends
Publications
0 total
Correction: Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases OA
Cited by 13
Semantic Scholar
Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases OA
Cited by 166
Semantic Scholar
Clinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy OA
Cited by 61
Semantic Scholar
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity OA
Cited by 67
Semantic Scholar
Dual light field and polarization imaging using CMOS diffractive image sensors.
Cited by 13
Semantic Scholar
Abstract P5-19-08: IMMU-132, a potential new antibody-drug conjugate (ADC) for the treatment of triple-negative breast cancer (TNBC): Preclinical and initial clinical results
Cited by 2
Semantic Scholar
Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
Cited by 46
Semantic Scholar
Abstract P5-19-27: IMMU-132, a new antibody-drug conjugate (ADC) against Trop-2, as a novel therapeutic for patients with relapsed/refractory, metastatic, triple-negative breast cancer (TNBC): Results from Phase I/II clinical trial (NCT01631552)
Cited by 4
Semantic Scholar
Research Topics
HER2/EGFR in Cancer Research
(19)
Growth Hormone and Insulin-like Growth Factors
(17)
Cancer, Hypoxia, and Metabolism
(11)
Radiopharmaceutical Chemistry and Applications
(11)
Cancer Treatment and Pharmacology
(11)
Affiliations
Hospital for Special Surgery
United States Food and Drug Administration
Ingalls Memorial Hospital
NewYork–Presbyterian Hospital
Howard Hughes Medical Institute